Clinical Laboratory Tests Market Size Worth $320.14 Billion By 2028 | CAGR: 7.3%: Polaris Market Research

NEW YORK, Sept. 15, 2021 /PRNewswire/ -- The global clinical laboratory tests market is anticipated to reach USD 320.14 billion by 2028.  according to a new study conducted by Polaris Market Research. the market is anticipated to register a CAGR of 7.3% from 2021-2028. The market growth is primarily driven by the growing geriatric population, increasing cases of cardiovascular and neurological diseases, and the rapid development of technologically advanced products. In addition to this, huge investments in the epidemiology of target diseases and an increasing number of anatomical pathology tests are complementing the overall growth of the market. The growing focus of government and private companies for the development of advanced laboratory testing procedures and increasing patient-centered approaches for effective disease management is expected to further augment the market progress.

Polaris Market Research Logo

Request for a sample report: https://www.polarismarketresearch.com/industry-analysis/clinical-laboratory-tests-market/request-for-sample

Key Highlights of Clinical Laboratory Tests Market

  • In terms of type, the metabolic clinical laboratory tests segment dominated the clinical laboratory tests market and is projected to maintain the same trend during the forecast period. This segment's growth is attributed to the increasing prevalence of lifestyle-borne diseases.
  • Based on end-use, the central laboratories segment accounted for the largest share in the market. An increasing number of central laboratories and rise in investment by key players to develop advanced solutions creating a positive outlook for the segment's growth.
  • Visby Medical announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its instrument-free Reverse Transcription (RT)-Polymerase Chain Reaction (PCR) COVID-19 test for testing pooled patient samples.
  • The Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) label for Quanterix Corporation's Quanterix Corporation's Simoa® SARS-CoV-2 N Protein Antigen Test to include testing with saliva and nasal swab samples.

Regional Developments

North America led the clinical laboratory tests market and is expected to grow substantially maintaining the same trend during the forecast period. Growing penetration of advanced diagnostic techniques, major improvements in the clinical space, and rising test volumes contributing to the regional market growth. On the other side, the regional market of Asia Pacific is predicted to witness the fastest growth rate during the forecast period, on account of rapid improvement in healthcare infrastructure allowing the quicker implementation of advanced diagnostic technologies. Additionally, growing avenues of scientific research and increasing investments from market participants further propelling market growth.

Have Any Query Or Specific Requirement? Feel Free To Ask Our Industry Experts At: https://www.polarismarketresearch.com/industry-analysis/clinical-laboratory-tests-market/speak-to-analyst

Competitive Outlook

Leading players operating in the market are giving more emphasis on addressing the requirements of robust healthcare systems. They are working on the development of advanced equipment and consumables that enable improved patient care in the management of different kinds of diseases. Some of the prominent players have received rapid accreditation for clinical laboratories helping them to expand their operations.

Abbott Labs; Bioscientia Institut für Medizinische Diagnostik GmbH; ARUP Laboratories; Tulip Diagnostics P Ltd.; Charles River; Sonic Healthcare; OPKO Health, Inc.; NeoGenomics Laboratories; Merck KgaA; Laboratory Corporation of America Holdings; Quest Diagnostics; Fresenius Medical Care; Genoptix, Inc.; Healthscope Ltd., QIAGEN; Siemens Healthcare, and Biosino Biotechnology and Science Inc. are among the global leader in the clinical laboratory tests market.

Target Audience

  • Supply Side: Diagnostic Company
  • Demand Side: Hospital, Clinics
  • Regulatory Side: World Health Organization

Polaris Market research has segmented the clinical laboratory tests market report on the basis of type, end-use, and region:

Clinical Laboratory Tests, Type Outlook (Revenue – USD Million, 2016 – 2028)

  • Complete Blood Count
  • HGB/HCT
  • Basic Metabolic Panel
  • BUN Creatinine Tests
  • Electrolytes Testing
  • HbA1c Tests
  • Comprehensive Metabolic Panel
  • Liver Panel
  • Renal Panel
  • Lipid Panel

Clinical Laboratory Tests, End Use Outlook (Revenue – USD Million, 2016 – 2028)

  • Central Laboratories
  • Primary Clinics

Clinical Laboratory Tests, by Regional Outlook (Revenue – USD Million, 2016 – 2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Indonesia
  • Central & South America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Buy Now this Premium Report to Grow your Business @ https://www.polarismarketresearch.com/checkouts/8211

OR

Find more research reports on Healthcare by PMR

Infection Surveillance Solutions Market Share, Size, Trends, Industry Analysis Report, By Product and Services (Software, {On-premise, Web-based}, and Services); By Infection Type (Surgical Site Infections, Blood Stream Infections, Urinary Tract Infections); By End-Use; By Regions; Segment Forecast, 2021 – 2028

Pharmacy Automation Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Medication Dispensing Systems, Packaging & Labeling Systems, Storage & Retrieval Systems, Automated Medication Compounding Systems, Tabletop Tablet Counters); By Application; By Regions; Segment Forecast, 2021 – 2028

Bioanalytical Testing Services Market Share, Size, Trends, Industry Analysis Report, By Molecule Type (Small Molecule, Large Molecule); By Test Type; By Workflow; By Region; Segment Forecast, 2021 – 2028

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:

Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-917-985-9017
Email: sales@polarismarketresearch.com 
Web: https://www.polarismarketresearch.com/ 
Follow US: LinkedIn | twitter

Cision View original content:https://www.prnewswire.com/news-releases/clinical-laboratory-tests-market-size-worth-320-14-billion-by-2028--cagr-7-3-polaris-market-research-301377277.html

SOURCE Polaris Market Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.